3 Penny Stocks With Market Caps Higher Than US$500M To Watch

In the dynamic world of penny stocks, some companies stand out with market capitalizations higher than US$500 million, offering investors the potential for substantial returns. These penny stocks, while still considered small-cap, have shown promising growth and have captured the attention of investors. Let's explore three penny stocks with market capitalizations higher than US$500 million that are worth watching.



1. Creo Medical Group (LSE: CREO)
Creo Medical Group, a medical device manufacturer, has a market capitalization of £73 million (US$95 million) and a share price of 18p. Despite a challenging five-year period, with the share price crashing 89%, the company has shown signs of improvement. Creo's recent share issue raised £12 million, providing much-needed cash to support its growth. The company's new product, Speedboat UltraSlim, has contributed to record core product sales in the first half of 2024. With a financial health rating of ★★★★☆☆, Creo's potential for growth and profitability in the coming years is worth watching.
2. Oxford Metrics (LSE: OMG)
Oxford Metrics, a smart sensing and motion-capture technology provider, has a market capitalization of £65 million (US$85 million) and a share price of 51p. The company's 2024 full-year results showed a decline in adjusted earnings per share and net cash, but its strong balance sheet and impressive customer list, including Boeing and Ford, make it an attractive investment opportunity. With a financial health rating of ★★★★☆☆, Oxford Metrics' potential for growth and recovery is worth keeping an eye on.
3. Inab IN8bio (NASDAQ: INAB)
Inab IN8bio, a biotechnology company focused on developing innovative cancer therapies, has a market capitalization of US$500 million and a share price of $1.25. The company's financial health rating of ★★★★★☆ reflects its strong fundamentals and growth potential. Inab IN8bio's pipeline of cancer therapies and its strategic partnerships with leading pharmaceutical companies position it well for future success. With a market cap above US$500 million, Inab IN8bio is a penny stock worth watching for its growth prospects and potential for significant returns.



In conclusion, penny stocks with market capitalizations higher than US$500 million offer investors the potential for substantial returns and growth. By keeping an eye on Creo Medical Group, Oxford Metrics, and Inab IN8bio, investors can position themselves to capitalize on the growth opportunities these penny stocks present. As always, thorough research and careful consideration of individual investment goals and risk tolerance are essential when investing in penny stocks.